Cigna Corp
NYSE:CI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Price/Premiums
Price to Premiums ratio compares an insurance company`s market value to the total premiums it earns. It shows how much investors are willing to pay for each dollar of premiums written by the insurer.
Price to Premiums ratio compares an insurance company`s market value to the total premiums it earns. It shows how much investors are willing to pay for each dollar of premiums written by the insurer.
Valuation Scenarios
If Price/Premiums returns to its 5-Year Average (0.5), the stock would be worth $0 (100% downside from current price).
| Scenario | Price/Premiums Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0 | $286.04 |
0%
|
| 5-Year Average | 0.5 | $0 |
-100%
|
| Industry Average | 0.6 | $0 |
-100%
|
| Country Average | 1.4 | $0 |
-100%
|
Forward Price/Premiums
Today’s price vs future gross premiums earned
Peer Comparison
| Market Cap | Price/Premiums | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Cigna Corp
NYSE:CI
|
74.4B USD | 0 | 12.7 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.6B USD | 0 | 58.4 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.3B EUR | 0 | 13.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.8B EUR | 0 | 23.1 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23B EUR | 0 | 18.2 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 0 | 21.2 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 0 | 24.4 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 0 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.6B USD | 0 | -25.9 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 0 | 13.8 | |
| US |
|
Brightspring Health Services Inc
NASDAQ:BTSG
|
9.3B USD | 0 | 0 |
Market Distribution
Other Multiples
Cigna Corp
Glance View
Cigna Corp., a stalwart in the healthcare sector, operates as a global health service company that skillfully navigates the intricacies of offering insurance and health-related products and services. Founded in 1982 from the merger of INA Corporation and Connecticut General Life Insurance Company, Cigna has entrenched itself as a key player in the industry. At its core, Cigna marries a robust understanding of healthcare with a sophisticated insurance model to address the diverse needs of individuals, employers, and governments. The company primarily generates revenue through insurance premiums, administrative service fees, and investment income. By providing an array of services, including medical, dental, and pharmacy benefits, as well as supplemental health and Medicare plans, Cigna captures a broad spectrum of the market, ensuring diversified revenue streams. The secret to Cigna’s enduring success lies in its commitment to innovation and integration within the healthcare space. By leveraging advanced technologies, Cigna enhances customer experiences and health outcomes, which, in turn, fortify its competitive edge. The company invests heavily in data analytics and personalized care, facilitating proactive health management that reduces costs and improves efficiency. Partnerships and collaborations with healthcare providers also play an instrumental role in controlling medical costs while maintaining quality care, underscoring its role as a pivotal intermediary between patients and providers. Through strategic acquisitions and expansions, such as its $67 billion acquisition of pharmacy benefit manager Express Scripts, Cigna continues to augment its service offerings, enabling synergies that amplify its reach and deepen its influence in the health services landscape.